Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Monotherapy)

NCT00868699 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

505

Enrollment

INDUSTRY

Sponsor class

Conditions

Bipolar Depression

Interventions

DRUG: lurasidone
DRUG: lurasidone
DRUG: Placebo

Sponsor

Sumitomo Pharma America, Inc.